APA (7th ed.) Citation

SD, B., RM, B., M, S., MR, N., ES, D., MR, P., . . . MP, B. (2022). Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. Journal of thrombosis and haemostasis : JTH, 20(5), 1193. https://doi.org/10.1111/jth.15673

Chicago Style (17th ed.) Citation

SD, Berkowitz, et al. "Prevention of Arterial and Venous Thrombotic Events in Symptomatic Peripheral Arterial Disease Patients After Lower Extremity Revascularization in the VOYAGER PAD Trial: Dual Anticoagulant/antiplatelet Regimen Vs Antiplatelet Therapy Alone." Journal of Thrombosis and Haemostasis : JTH 20, no. 5 (2022): 1193. https://doi.org/10.1111/jth.15673.

MLA (9th ed.) Citation

SD, Berkowitz, et al. "Prevention of Arterial and Venous Thrombotic Events in Symptomatic Peripheral Arterial Disease Patients After Lower Extremity Revascularization in the VOYAGER PAD Trial: Dual Anticoagulant/antiplatelet Regimen Vs Antiplatelet Therapy Alone." Journal of Thrombosis and Haemostasis : JTH, vol. 20, no. 5, 2022, p. 1193, https://doi.org/10.1111/jth.15673.